96 related articles for article (PubMed ID: 1411633)
21. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer.
Murad AM; Triginelli SA; Ribalta JC
J Clin Oncol; 1994 Jan; 12(1):55-9. PubMed ID: 7505808
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
Sutton GP; Blessing JA; McGuire WP; Patton T; Look KY
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
[TBL] [Abstract][Full Text] [Related]
23. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP
Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
[TBL] [Abstract][Full Text] [Related]
24. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of ifosfamide in cervical cancer.
Meanwell CA; Mould JJ; Blackledge G; Lawton FG; Stuart NS; Kavanagh J; Latief TN; Spooner D; Chetiyawardana AD
Cancer Treat Rep; 1986 Jun; 70(6):727-30. PubMed ID: 3089596
[TBL] [Abstract][Full Text] [Related]
26. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
[TBL] [Abstract][Full Text] [Related]
28. Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.
Downs LS; Chura JC; Argenta PA; Judson PL; Ghebre R; Geller MA; Carson LF
Gynecol Oncol; 2011 Feb; 120(2):265-9. PubMed ID: 21145100
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study.
Kumar L; Kaushal R; Nandy M; Biswal BM; Kumar S; Kriplani A; Singh R; Rath GK; Kochupillai V
Gynecol Oncol; 1994 Sep; 54(3):307-15. PubMed ID: 7522200
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma.
Lara PC; Garcia-Puche JL; Pedraza V
Cancer Chemother Pharmacol; 1990; 26 Suppl():S36-8. PubMed ID: 2347047
[TBL] [Abstract][Full Text] [Related]
33. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Smith IE; Perren TJ; Ashley SA; Woodiwiss J; Forgeson GV; Yarnold JR; Ford HT
J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
[TBL] [Abstract][Full Text] [Related]
34. The role of ifosfamide in cervical cancer.
Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
[TBL] [Abstract][Full Text] [Related]
35. A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
Elias AD; Ayash LJ; Eder JP; Wheeler C; Deary J; Weissman L; Schryber S; Hunt M; Critchlow J; Schnipper L
J Clin Oncol; 1991 Feb; 9(2):320-7. PubMed ID: 1846407
[TBL] [Abstract][Full Text] [Related]
36. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
37. Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
Cervellino JC; Araujo CE; Pirisi C; Sanchez O; Brosto M; Rossi R
Cancer Chemother Pharmacol; 1990; 26 Suppl():S1-3. PubMed ID: 2112052
[TBL] [Abstract][Full Text] [Related]
38. Carboplatin-based combination chemotherapy for advanced carcinoma of the cervix.
Junor E; Davies J; Habeshaw T; Kaye S; Paul J; Rankin E; Reed N; Symonds RP
Cancer Chemother Pharmacol; 1991; 27(6):484-6. PubMed ID: 1707350
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E
J Infus Chemother; 1996; 6(1):39-42. PubMed ID: 8748006
[TBL] [Abstract][Full Text] [Related]
40. Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
Chang AY; Asbury RF; Boros L; Garrow GC; Hsieh S
Semin Oncol; 1995 Jun; 22(3 Suppl 7):9-12. PubMed ID: 7610399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
